Cargando…

Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries

BACKGROUND: National Immunisation Technical Advisory Groups (NITAGs) are multi-disciplinary expert groups that provide policy-makers with independent, evidence-based advice on vaccination. Between 2008 and 2017, the SIVAC Initiative supported establishment and strengthening of NITAGs in low and lowe...

Descripción completa

Detalles Bibliográficos
Autores principales: van Zandvoort, Kevin, Howard, Natasha, Mounier-Jack, Sandra, Jit, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334253/
https://www.ncbi.nlm.nih.gov/pubmed/30545715
http://dx.doi.org/10.1016/j.vaccine.2018.11.070
_version_ 1783387678695227392
author van Zandvoort, Kevin
Howard, Natasha
Mounier-Jack, Sandra
Jit, Mark
author_facet van Zandvoort, Kevin
Howard, Natasha
Mounier-Jack, Sandra
Jit, Mark
author_sort van Zandvoort, Kevin
collection PubMed
description BACKGROUND: National Immunisation Technical Advisory Groups (NITAGs) are multi-disciplinary expert groups that provide policy-makers with independent, evidence-based advice on vaccination. Between 2008 and 2017, the SIVAC Initiative supported establishment and strengthening of NITAGs in low and lower-middle income countries though its impact was never assessed quantitatively. AIM: To quantitatively assess whether SIVAC support is associated with a faster rate at which NITAGs became functional based on six performance indicators. METHODS: Data from the World Health Organization/Unicef Joint Reporting Form (JRF) from 77 low and lower-middle-income countries were used to examine the time delay between the start of SIVAC support and NITAG functionality using a Cox proportional hazards model. RESULTS: Countries receiving SIVAC support took a mean of 2.00 (95% CI 1.40–2.60) years to reported functionality compared to 2.82 (95% CI 2.05–3.59) years for countries without SIVAC support. We found evidence that SIVAC support is associated with reduced time until NITAG functionality, and this association cannot fully be explained by GDP per capita, percentage of GDP spent on healthcare, or NITAG functionality score at the start of the study period. However, quality of JRF data for the questions used to calculate NITAG functionality were poor, particularly for countries not receiving SIVAC support. CONCLUSION: SIVAC support is likely to have enabled many countries to more rapidly achieve NITAG functionality.
format Online
Article
Text
id pubmed-6334253
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-63342532019-01-22 Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries van Zandvoort, Kevin Howard, Natasha Mounier-Jack, Sandra Jit, Mark Vaccine Article BACKGROUND: National Immunisation Technical Advisory Groups (NITAGs) are multi-disciplinary expert groups that provide policy-makers with independent, evidence-based advice on vaccination. Between 2008 and 2017, the SIVAC Initiative supported establishment and strengthening of NITAGs in low and lower-middle income countries though its impact was never assessed quantitatively. AIM: To quantitatively assess whether SIVAC support is associated with a faster rate at which NITAGs became functional based on six performance indicators. METHODS: Data from the World Health Organization/Unicef Joint Reporting Form (JRF) from 77 low and lower-middle-income countries were used to examine the time delay between the start of SIVAC support and NITAG functionality using a Cox proportional hazards model. RESULTS: Countries receiving SIVAC support took a mean of 2.00 (95% CI 1.40–2.60) years to reported functionality compared to 2.82 (95% CI 2.05–3.59) years for countries without SIVAC support. We found evidence that SIVAC support is associated with reduced time until NITAG functionality, and this association cannot fully be explained by GDP per capita, percentage of GDP spent on healthcare, or NITAG functionality score at the start of the study period. However, quality of JRF data for the questions used to calculate NITAG functionality were poor, particularly for countries not receiving SIVAC support. CONCLUSION: SIVAC support is likely to have enabled many countries to more rapidly achieve NITAG functionality. Elsevier Science 2019-01-14 /pmc/articles/PMC6334253/ /pubmed/30545715 http://dx.doi.org/10.1016/j.vaccine.2018.11.070 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
van Zandvoort, Kevin
Howard, Natasha
Mounier-Jack, Sandra
Jit, Mark
Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries
title Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries
title_full Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries
title_fullStr Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries
title_full_unstemmed Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries
title_short Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries
title_sort strengthening national vaccine decision-making: assessing the impact of sivac initiative support on national immunisation technical advisory group (nitag) functionality in 77 low and middle-income countries
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334253/
https://www.ncbi.nlm.nih.gov/pubmed/30545715
http://dx.doi.org/10.1016/j.vaccine.2018.11.070
work_keys_str_mv AT vanzandvoortkevin strengtheningnationalvaccinedecisionmakingassessingtheimpactofsivacinitiativesupportonnationalimmunisationtechnicaladvisorygroupnitagfunctionalityin77lowandmiddleincomecountries
AT howardnatasha strengtheningnationalvaccinedecisionmakingassessingtheimpactofsivacinitiativesupportonnationalimmunisationtechnicaladvisorygroupnitagfunctionalityin77lowandmiddleincomecountries
AT mounierjacksandra strengtheningnationalvaccinedecisionmakingassessingtheimpactofsivacinitiativesupportonnationalimmunisationtechnicaladvisorygroupnitagfunctionalityin77lowandmiddleincomecountries
AT jitmark strengtheningnationalvaccinedecisionmakingassessingtheimpactofsivacinitiativesupportonnationalimmunisationtechnicaladvisorygroupnitagfunctionalityin77lowandmiddleincomecountries